Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Pituitary tumour
ADR ID BADD_A03432
ADR Hierarchy
05      Endocrine disorders
05.03      Hypothalamus and pituitary gland disorders
05.03.05      Pituitary neoplasms
05.03.05.002      Pituitary tumour
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.24      Endocrine neoplasms malignant and unspecified
16.24.01      Endocrine neoplasms malignant and unspecified NEC
16.24.01.003      Pituitary tumour
Description Not Available
MedDRA Code 10035104
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Neoplasm of uncertain behavior of pituitary gland and craniopharyngeal duct | Neoplasm of uncertain behaviour of pituitary gland and craniopharyngeal duct | Pituitary gland neoplasm | Pituitary neoplasm NOS | Pituitary tumor NOS | Pituitary tumour | Pituitary tumour NOS
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00165Aripiprazole0.000079%
BADD_D00329Cabergoline0.009609%
BADD_D00497Clomiphene--
BADD_D00498Clomiphene citrate--
BADD_D00680Dimethyl fumarate--
BADD_D00852Etonogestrel0.000917%
BADD_D01038Goserelin--
BADD_D01039Goserelin acetate--
BADD_D01253Lenalidomide0.000603%
BADD_D01254Lenvatinib--
BADD_D01336Macitentan0.000120%
BADD_D01656Paliperidone0.008879%
BADD_D01951Risperidone0.000242%
BADD_D01971Rosuvastatin0.000017%
BADD_D02047Sodium oxybate0.000536%
BADD_D02098Sumatriptan--
BADD_D02099Sumatriptan succinate--
BADD_D02100Sunitinib0.000112%
BADD_D02375Water--
BADD_D02412Octreotide--
The 1th Page    1    Total 1 Pages